Business Context and Reporting Period
This Form 8-K filing by Shuttle Pharmaceuticals Holdings, Inc. (SHPH) is dated September 10, 2024. The report addresses a regulatory notice received from The Nasdaq Capital Market regarding the company's compliance with continued listing standards.
Key Financial Metrics
The filing references financial data from the company's Quarterly Report on Form 10-Q for the period ended June 30, 2024.
- Stockholders' Equity: $801,434
- Nasdaq Minimum Requirement: $2,500,000
- Compliance Status: Non-compliant with Nasdaq Listing Rule 5550(b)(1).
The filing text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity beyond the stockholders' equity figure.
Material Changes and Listing Status
On September 10, 2024, the company received a notification from Nasdaq stating it failed to meet the minimum stockholders' equity requirement. The company also does not currently meet alternative listing standards regarding the market value of listed securities or net income from continuing operations. This notification does not immediately delist the securities but initiates a compliance process.
Outlook, Risks, and Management Commentary
Compliance Timeline:
- The company has 45 calendar days (until October 25, 2024) to submit a plan to regain compliance.
- If the plan is accepted, Nasdaq may grant an extension of up to 180 calendar days from September 10, 2024, to achieve compliance.
Risks and Contingencies:
- There is no assurance that the company's compliance plan will be accepted by Nasdaq.
- Even if accepted, there is no assurance the company will successfully regain compliance within the granted timeframe.
- Failure to regain compliance or satisfy other listing requirements could result in a delisting notice.
- In the event of a delisting notice, the company retains the right to appeal to a hearings panel.
Management Action: The company is currently evaluating various courses of action to regain compliance and intends to submit a plan timely.
Investor Verification Checklist
- Verify the specific details of the compliance plan the company intends to submit by October 25, 2024.
- Monitor the company's stockholders' equity levels in subsequent filings to assess progress toward the $2.5 million threshold.
- Check for any announcements regarding Nasdaq's acceptance or rejection of the compliance plan.
- Review the June 30, 2024 Form 10-Q for a complete picture of the company's financial health, including cash position and burn rate.